Deborah M.  Autor net worth and biography

Deborah Autor Biography and Net Worth

Insider of Hims & Hers Health

Deb Autor has been a member of our Board of Directors since November 2024. She serves as Hims & Hers’ Chief Policy Officer, a role she assumed in November 2025; a Board Director of Amneal Pharmaceuticals, Inc. (AMRX); and Chair of the Board of the FDA Alumni Association. Ms. Autor has also served as CEO of strategic regulatory consulting firms Healthcare Innovation Catalysts, Inc. and Autor Strategies, LLC. She was previously a Board member of Pardes Biosciences, Inc. (PRDS); the Antimicrobial Resistance Industry Alliance; and the Parenteral Drug Association. She has also served as a Scientific Advisory Council Member of the Centre for Innovation in Regulatory Science and as an Advisory Board Member of the United States Pharmacopoeia Quality Institute. From 2019-2021, Ms. Autor was Global Head of Regulatory Excellence at AstraZeneca, where she led regulatory operations, policy and intelligence for AstraZeneca submissions globally. Before joining AstraZeneca, Ms. Autor served at Mylan N.V. from 2013-2019, where she was Head of Strategic Global Quality and Regulatory Policy and Head of Global Quality. Ms. Autor was a senior leader at the FDA from 2001-2013, most recently as Deputy Commissioner for Global Regulatory Operations and Policy where she oversaw all FDA inspections, criminal investigations and international operations for human and veterinary drugs, biologics, medical devices, tobacco and food. Before that, Ms. Autor served as Director of the Office of Compliance of the Center for Drug Evaluation and Research, leading enforcement and policy making for compliance with requirements relating to drug approval; current good manufacturing practices (GMP); human subject protection and bioresearch monitoring (GCP); pharmacy compounding; import and export; and recalls, among others. Before joining the FDA, Ms. Autor was a Trial Attorney in the Office of Consumer Litigation of the U.S. Department of Justice, where she litigated civil and criminal cases on behalf of the FDA. Ms. Autor received a Juris Doctor, Magna Cum Laude, from Boston University School of Law and a Bachelor of Arts in Psychology from Columbia University, Barnard College.

What is Deborah M. Autor's net worth?

The estimated net worth of Deborah M. Autor is at least $198.88 thousand as of December 17th, 2025. Autor owns 6,175 shares of Hims & Hers Health stock worth more than $198,884 as of January 13th. This net worth approximation does not reflect any other investments that Autor may own. Learn More about Deborah M. Autor's net worth.

How do I contact Deborah M. Autor?

The corporate mailing address for Autor and other Hims & Hers Health executives is 2269 CHESTNUT STREET SUITE 523, SAN FRANCISCO CA, 94123. Hims & Hers Health can also be reached via phone at 415-851-0195 and via email at [email protected]. Learn More on Deborah M. Autor's contact information.

Has Deborah M. Autor been buying or selling shares of Hims & Hers Health?

Deborah M. Autor has not been actively trading shares of Hims & Hers Health in the last ninety days. Most recently, Deborah M. Autor sold 7,054 shares of the business's stock in a transaction on Wednesday, December 17th. The shares were sold at an average price of $36.71, for a transaction totalling $258,952.34. Following the completion of the sale, the insider now directly owns 6,175 shares of the company's stock, valued at $226,684.25. Learn More on Deborah M. Autor's trading history.

Who are Hims & Hers Health's active insiders?

Hims & Hers Health's insider roster includes Jack Abraham (Major Shareholder), Deborah Autor (Insider), Melissa Baird (COO), Irene Becklund (Insider), Irene Becklund (Insider), Soleil Boughton (Insider), Patrick Carroll (Insider), Michael Chi (Chief Commercial Officer), Andrew Dudum (Co-Founder, Chairman & CEO), Spencer Lee (CFO), Anja Manuel (Director), Oluyemi Okupe (CFO), Christopher Payne (Director), and David Wells (Director). Learn More on Hims & Hers Health's active insiders.

Are insiders buying or selling shares of Hims & Hers Health?

In the last year, insiders at the sold shares 91 times. They sold a total of 3,273,699 shares worth more than $155,509,033.52. The most recent insider tranaction occured on January, 5th when CFO Oluyemi Okupe sold 9,070 shares worth more than $306,475.30. Insiders at Hims & Hers Health own 17.7% of the company. Learn More about insider trades at Hims & Hers Health.

Information on this page was last updated on 1/5/2026.

Deborah M. Autor Insider Trading History at Hims & Hers Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/17/2025Sell7,054$36.71$258,952.346,175View SEC Filing Icon  
See Full Table

Deborah M. Autor Buying and Selling Activity at Hims & Hers Health

This chart shows Deborah M Autor's buying and selling at Hims & Hers Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Hims & Hers Health Company Overview

Hims & Hers Health logo
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Read More

Today's Range

Now: $32.21
Low: $31.71
High: $33.27

50 Day Range

MA: $36.43
Low: $31.69
High: $43.75

2 Week Range

Now: $32.21
Low: $23.97
High: $72.98

Volume

15,214,447 shs

Average Volume

11,965,346 shs

Market Capitalization

$7.33 billion

P/E Ratio

59.64

Dividend Yield

N/A

Beta

2.37